The beneficial effects of newer antidiabetic drugs(Sodium Glucose Co-Transporters type 2) inhibitors for the treatment of raised blood glucose level
Not Applicable
- Conditions
- Health Condition 1: E11- Type 2 diabetes mellitus
- Registration Number
- CTRI/2019/03/018307
- Lead Sponsor
- Jawaharlal Nehru Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients having age 18 years and above with type 2 DM on SGLT2 inhibitors and/ or
on other oral antidiabetics
Exclusion Criteria
Type 1 Diabetes Mellitus
Patients on insulin or other injectable agents
Patients on systemic corticosteroids and other drugs which may affect the glycaemic
parameters
History of Diabetic Ketoacidosis (DKA)
Significant Diabetic nephropathy
Patients with significant liver disease
Congestive Heart Failure (CHF)
Patients with significant lung disease
Septicaemia
Psychotic patient
Pregnancy
Known cases of HIV / HBsAg / Anti-HCV and immunocompromised patients
Any other severe systemic illness
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method